The DOI matches its Crossref record, with a small difference in title or year; 36 of the 36 references it cites were found in a registry or an index.
Early Protection Against Sudden Death by n-3 Polyunsaturated Fatty Acids After Myocardial Infarction: Time-Course Analysis of the Results of the Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico (GISSI)-Prevenzione
Abstract
Background — Our purpose was to assess the time course of the benefit of n-3 polyunsaturated fatty acids (PUFAs) on mortality documented by the GISSI-Prevenzione trial in patients surviving a recent (<3 months) myocardial infarction. Methods and Results — In this study, 11 323 patients were randomly assigned to supplements of n-3 PUFAs, vitamin E (300 mg/d), both, or no treatment (control) on top of optimal pharmacological treatment and lifestyle advice. Intention-to-treat analysis adjusted for interaction between treatments was carried out. Early efficacy of n-3 PUFA treatment for total, cardiovascular, cardiac, coronary, and sudden death; nonfatal myocardial infarction; total coronary heart disease; and cerebrovascular events was assessed by right-censoring follow-up data 12 times from the first month after randomization up to 12 months. Survival curves for n-3 PUFA treatment diverged early after randomization, and total mortality was significantly lowered after 3 months of treatment (relative risk [RR] 0.59; 95% CI 0.36 to 0.97; P =0.037). The reduction in risk of sudden death was specifically relevant and statistically significant already at 4 months (RR 0.47; 95% CI 0.219 to 0.995; P =0.048). A similarly significant, although delayed, pattern after 6 to 8 months of treatment was observed for cardiovascular, cardiac, and coronary deaths. Conclusions — The early effect of low-dose (1 g/d) n-3 PUFAs on total mortality and sudden death supports the hypothesis of an antiarrhythmic effect of this drug. Such a result is consistent with the wealth of evidence coming from laboratory experiments on isolated myocytes, animal models, and epidemiological and clinical studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“contemporary high-intensity statin formulations achieve greater low-density lipoprotein–lowering effects and cardiovascular endpoint reduction than were used during the first mixed EPA/DHA trials, such as GISSI-P.17,27,44”
From Effects of Eicosapentaenoic Acid vs Eicosapentaenoic/Docosahexaenoic Acids on Cardiovascular Mortality (2025) · cites this paper as [44]
Experimental — accuracy not yet measuredIn the citing paper
“Data from meta-analyses suggest that a reduction of calculated glomerular filtration rate (GFR) does not reflect any adverse effects on kidney function [315].”
From 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk (2019) · cites this paper as [315]
In the citing paper
“Results from other meta-analyses suggest reduced major CVD events in patients with high TGs and low HDL-C in fibrate-treated patients, but no decrease in CVD or total mortality [314-316].”
From 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk (2019) · cites this paper as [315]
In the citing paper
“A post hoc subgroup analysis revealed that this reduction in mortality and SCD was concentrated in the approximately 2000 patients with reduced left ventricular ejection fraction [67].”
From Update on Omega-3 Polyunsaturated Fatty Acids on Cardiovascular Health (2022) · cites this paper as [67]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
de Lorgeril, M., Salen, P., Martin, J.-L., Monjaud, I., Delaye, J., & Mamelle, N. (1999) · Circulation · doi:10.1161/01.cir.99.6.779 · Cited by 2,910
Burr, M. L., Gilbert, J. F., Holliday, R. M., Elwood, P. C., Fehily, A. M., Rogers, S., Sweetnam, P. M., & Deadman, N. M. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90828-3 · Cited by 2,610
The Inverse Relation between Fish Consumption and 20-Year Mortality from Coronary Heart Disease
Kromhout, D., Bosschieter, E. B., & Coulander, C. D. L. (1985) · New England Journal of Medicine · doi:10.1056/nejm198505093121901 · Cited by 2,177
(1999) · PubMed · Cited by 2,062
Self-citationn-3 fatty acids and serum lipoproteins: human studies
Harris, W. (1997) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/65.5.1645s · Cited by 1,243
Fish Consumption and Risk of Sudden Cardiac Death
Albert, C. M. (1998) · JAMA · doi:10.1001/jama.279.1.23 · Cited by 990
The Composition of Food Consumed by Greenland Eskimos
Bang, H. O., Dyerberg, J., & Hjørne, N. (1976) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1976.tb08198.x · Cited by 950
Siscovick, D. S. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03530170043030 · Cited by 920
Fish consumption and the 30-year risk of fatal myocardial infarction
Daviglus, M. L., Stamler, J., Orencia, A. J., Dyer, A. R., Liu, K., Greenland, P., Walsh, M. K., Morris, D., & Shekelle, R. B. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704103361502 · Cited by 902
Research works printed but not linked: 10
Cited by
Sorted by citations
Items 701–800 of 1,000
Sun, Y. J., Koh, W., Yuan, J., Choi, H., Su, J., Ong, C. N., & van Dam, R. M. (2015) · Journal of Nutrition · doi:10.3945/jn.115.220418 · Cited by 17
Abnormalities in the fatty-acid composition of the serum phospholipids of stroke patients.
Glew, R. H., Okolie, H. I., Huang, Y. S., Chuang, L., Suberu, O., Crossey, M., & VanderJagt, D. J. (2004) · PubMed · Cited by 17
Clinical Update on Nursing Home Medicine: 2008
Messinger‐Rapport, B. J., Thomas, D. R., Gammack, J. K., & Morley, J. E. (2008) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2008.07.006 · Cited by 17
Geelen, A., Zock, P. L., Brouwer, I. A., Katan, M., Kors, J. A., van Eck, H. J. R., & Schouten, E. G. (2005) · British Journal Of Nutrition · doi:10.1079/bjn20051429 · Cited by 17
A fishy business: omega-3 fatty acids and cardiovascular disease
Wierzbicki, A. S. (2008) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2008.01781.x · Cited by 16
Atrial Fibrillation and Heart Failure With Reduced Ejection Fraction
Zeitler, E. P., Johnson, A. E., Cooper, L. B., Steinberg, B. A., & Houston, B. A. (2024) · JACC Heart Failure · doi:10.1016/j.jchf.2024.06.016 · Cited by 17
Rauch, B. H., & Senges, J. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00057 · Cited by 16
Harris, K. A., Fleming, J. A., & Kris‐Etherton, P. M. (2011) · Journal of Food Composition and Analysis · doi:10.1016/j.jfca.2011.03.019 · Cited by 16
Lipid Regulation of Sodium Channels
D’Avanzo, N. (2016) · Current topics in membranes · doi:10.1016/bs.ctm.2016.04.003 · Cited by 17
Enzymes for Use in Functional Foods
Agyei, D., Akanbi, T. O., & Oey, I. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813280-7.00009-8 · Cited by 17
Effects of ω-3 PUFA and ascorbic acid combination on post-resuscitation myocardial function
Cheng, C., Li, H., Liang, L., Jin, T., Zhang, G., Bradley, J. L., Peberdy, M. A., Ornato, J. P., Wijesinghe, D. S., & Tang, W. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110970 · Cited by 16
Resolvins and protectins: novel lipid mediators in anti-inflammation and resolution
Serhan, C. N. (2006) · Scandinavian Journal of Food & Nutrition · doi:10.1080/17482970601066298 · Cited by 17
Park, Y., Lim, J., Kwon, Y., & Lee, J. (2009) · Nutrition Research · doi:10.1016/j.nutres.2009.05.010 · Cited by 16
What Combination Therapy with a Statin, If Any, Would You Recommend?
Dujovne, C. A., Williams, C. D., & Ito, M. K. (2010) · Current Atherosclerosis Reports · doi:10.1007/s11883-010-0150-3 · Cited by 17
Le, P. M., Fraser, C. C., Gardner, G. J., Liang, W.-W. S., Kralovec, J. A., Cunnane, S. C., & Windust, A. J. (2007) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-007-1305-0 · Cited by 16
Fish oil in primary and secondary cardiovascular prevention.
Artham, S. M., Lavie, C. J., Milani, R. V., Anand, R. G., O’Keefe, J. H., & Ventura, H. O. (2008) · PubMed Central · Cited by 15
A review of the biologic and pharmacological role of docosapentaenoic acid
Yazdi, P. G. (2013) · F1000Research · doi:10.12688/f1000research.2-256.v1 · Cited by 17
Lifestyle and dietary modification for prevention of heart failure
Katz, D. L. (2004) · Medical Clinics of North America · doi:10.1016/j.mcna.2004.02.003 · Cited by 16
McManus, A., Howieson, J., & Nicholson, C. (2009) · eSpace (Curtin University) · Cited by 16
Omega-3 Fatty Acid Supplementation and Cardiovascular Disease Events
Vlachopoulos, C., Richter, D. J., & Stefanadis, C. (2013) · JAMA · doi:10.1001/jama.2012.116651 · Cited by 16
Markozannes, G., Ntzani, E. E., Tsapas, A., Mantzoros, C. S., Tsiara, S., Xanthos, T., Karpettas, N., Patrikios, I., & Rizos, E. C. (2022) · Clinical Nutrition · doi:10.1016/j.clnu.2022.02.022 · Cited by 16
Hall, W. L., Hay, G., Maniou, Z., Seed, P. T., Chowienczyk, P., & Sanders, T. A. B. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.06.153 · Cited by 15
Kuipers, R. S., Luxwolda, M. F., Dijck-Brouwer, J., & Muskiet, F. A. J. (2011) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2011.04.015 · Cited by 15
Bouriga, N., Selmi, S., Faure, É., & Trabelsi, M. (2010) · AFRICAN JOURNAL OF BIOTECHNOLOGY · doi:10.5897/ajb2010.000-3294 · Cited by 15
Atrial Remodeling And Atrial Fibrillation: Mechanistic Interactions And Clinical Implications.
Ghamdi, B. A., & Hassan, W. (2009) · Europe PMC (PubMed Central) · doi:10.4022/jafib.125 · Cited by 15
Ácidos grasos omega-3 de pescado y riesgo de enfermedad coronaria
Alonso, Á., Martínez‐González, M. Á., & Serrano-Martínez, M. (2003) · Medicina Clínica · doi:10.1016/s0025-7753(03)74116-5 · Cited by 16
Evidence-Based Cardiovascular Risk Management in Diabetes
Mooradian, A. D. (2019) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-019-00336-6 · Cited by 16
Omega-3 fatty acids: How can they be used in secondary prevention?
Τζιόμαλος, Κ., Athyros, V. G., Karagiannis, A. I., & Mikhailidis, D. P. (2008) · Current Atherosclerosis Reports · doi:10.1007/s11883-008-0079-y · Cited by 15
Watanabe, S., Yoshihisa, A., Kanno, Y., Takiguchi, M., Yokokawa, T., Sato, A., Miura, S., Shimizu, T., Abe, S., Sato, T., et al. (2016) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2016.04.017 · Cited by 15
Oh, R., Beresford, S. A. A., & Lafferty, W. E. (2006) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.19.5.459 · Cited by 14
Omega-3 Fatty Acids, Ventricular Arrhythmias, and Sudden Cardiac Death
Albert, C. M. (2012) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.112.971416 · Cited by 15
Suyun Biyokimyası ve Fonksiyonları
Akbağ, H. I. (2024) · Akademisyen Kitabevi eBooks · doi:10.37609/akya.3266.c9392 · Cited by 14
Greene, S. J., Temporelli, P. L., Campia, U., Vaduganathan, M., Esposti, L. D., Buda, S., Veronesi, C., Butler, J., & Nodari, S. (2015) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2015.10.050 · Cited by 14
The journey of omega-3 fatty acids in cardiovascular medicine
Ferrari, R., Censi, S., & Cimaglia, P. (2020) · European Heart Journal Supplements · doi:10.1093/eurheartj/suaa118 · Cited by 15
Freije, A. M. (2009) · Journal of Oleo Science · doi:10.5650/jos.58.379 · Cited by 14
Hande, L. N., Thunhaug, H., Enebakk, T., Ludviksen, J. K., Pettersen, K., Hovland, A., & Lappegård, K. T. (2019) · Journal of clinical lipidology · doi:10.1016/j.jacl.2019.08.004 · Cited by 15
Practical algorithms for pharmacologic management of the post myocardial infarction patient
Reiffel, J. A. (2009) · Clinical Cardiology · doi:10.1002/clc.4960281306 · Cited by 14
Effect of n-3 Polyunsaturated Fatty Acids on Risk Reduction of Sudden Death
Jones, P. J. H., & Lau, V. W. (2002) · Nutrition Reviews · doi:10.1301/002966402320964070 · Cited by 15
Voulgari, C., & Tentolouris, N. (2009) · Current Cardiology Reviews · doi:10.2174/157340309789317850 · Cited by 14
Polyunsaturated fatty acids for prevention of atrial fibrillation: a 'fishy' story
Savelieva, I., & Camm, A. J. (2011) · EP Europace · doi:10.1093/europace/euq520 · Cited by 14
Gaeini, Z., Mirmiran, P., Bahadoran, Z., Aghayan, M., & Azizi, F. (2021) · Nutrition & Metabolism · doi:10.1186/s12986-021-00624-6 · Cited by 16
Effect of a High Linoleic Acid Diet on Pregnant Women and Their Offspring
Nayyar, D., Said, J. M., McCarthy, H., Hryciw, D. H., O’Keefe, L., & McAinch, A. J. (2024) · Nutrients · doi:10.3390/nu16173019 · Cited by 13
Delayed and Indirect Effects of Antiarrhythmic Drugs in Reducing Sudden Cardiac Death
Malhotra, S., & Das, M. K. (2011) · Future Cardiology · doi:10.2217/fca.11.3 · Cited by 13
Brock, T. G. (2007) · Lipids · doi:10.1007/s11745-007-3136-3 · Cited by 13
The pro- or antiarrhythmic actions of polyunsaturated fatty acids and of cholesterol
Coronel, R. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.02.004 · Cited by 14
on behalf of J-MINUET investigators, Hashimoto, T., Ako, J., Nakao, K., Ozaki, Y., Kimura, K., Noguchi, T., Yasuda, S., Suwa, S., Fujimoto, K., et al. (2017) · Heart and Vessels · doi:10.1007/s00380-017-1084-2 · Cited by 13
A High‐Throughput Method for the Analysis of Erythrocyte Fatty Acids and the Omega‐3 Index
Alqarni, A., Mcintyre, K. J., Brown, S. H. J., Meyer, B. J., & Mitchell, T. W. (2018) · Lipids · doi:10.1002/lipd.12108 · Cited by 16
Specialized Pro-Resolving Lipid Mediators in Neonatal Cardiovascular Physiology and Diseases
Gila-Díaz, A., Carrillo, G. H., Singh, P., & Ramiro‐Cortijo, D. (2021) · Antioxidants · doi:10.3390/antiox10060933 · Cited by 13
The cardiovascular implications of omega-3 fatty acids
Block, R., & Pearson, T. A. (2006) · Via Medica Journals · Cited by 13
Kawaharada, R., Nakamura, A., Kakarla, S. K., Blough, E. R., Kohama, K., & Kohama, T. (2013) · Nutrition · doi:10.1016/j.nut.2012.11.017 · Cited by 13
Din, J. N., Sarma, J., Harding, S. A., Lyall, K., Newby, D. E., & Flapan, A. D. (2013) · BMJ Open · doi:10.1136/bmjopen-2013-003054 · Cited by 13
Libinaki, R., Vinh, A., Tesanovic, S., Widdop, R. E., & Gaspari, T. A. (2017) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12821 · Cited by 13
Dietary Fats and Blood Pressure
Mori, T. A., Burke, V., & Beilin, L. J. (2007) · Elsevier eBooks · doi:10.1016/b978-0-323-03961-1.50010-6 · Cited by 13
Omega-3 fatty acids and risk of cardiovascular disease in Inuit: First prospective cohort study
Senftleber, N. K., Albrechtsen, A., Lauritzen, L., Larsen, C. V. L., Bjerregaard, P., Díaz, L. J., Rønn, P. F., & Jørgensen, M. E. (2020) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2020.08.032 · Cited by 15
Muroya, T., Kawano, H., Koga, S., Ikeda, S., Yamamoto, F., & Maemura, K. (2020) · Internal Medicine · doi:10.2169/internalmedicine.5401-20 · Cited by 13
Tamai, T., Murota, I., Maruyama, K., Baba, T., Toyama, T., Watanabe, N., Kudo, N., & Kawashima, Y. (2007) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.30.2381 · Cited by 13
Engler, M. M., Engler, M. B., Arterburn, L. M., Bailey, E., Chiu, E. Y., Malloy, M. J., & Mietus‐Snyder, M. (2004) · Nutrition Research · doi:10.1016/j.nutres.2004.06.004 · Cited by 13
Dietary fatty acids and inflammation
Clifton, P. M. (2009) · Nutrition & Dietetics · doi:10.1111/j.1747-0080.2008.01311.x · Cited by 13
Wang, J., & Shahidi, F. (2011) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf200039j · Cited by 13
Diet and cardiovascular disease: Beyond cholesterol
Rivellese, A. A. (2005) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2005.10.004 · Cited by 13
Fat as a physiological regulator: the news gets better
Calder, P. C., & Deckelbaum, R. J. (2003) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/00075197-200303000-00001 · Cited by 13
The Fish Oil Story Remains Fishy
Eckel, R. H. (2010) · Circulation · doi:10.1161/circulationaha.110.986976 · Cited by 13
Rupp, T. P., Rupp, K. G., Alter, P., & Rupp, H. (2013) · Cardiology · doi:10.1159/000350656 · Cited by 12
Tereshchenko, S. N., Жиров, И. В., Uskach, T. M., Saidova, M. A., Sp, G., Михайловна, Г. Е., Николаевна, Н. С., Narusov, O. Y., Safiullina, A. A., Tereshchenko, A. S., et al. (2020) · Eurasian heart journal · doi:10.38109/2225-1685-2020-3-6-76 · Cited by 12
New approaches to therapy with omega-3 fatty acids
Kakar, P., Watson, T., & Lip, G. Y. H. (2008) · Current Atherosclerosis Reports · doi:10.1007/s11883-008-0012-4 · Cited by 13
Effects of Malania oleifera Chun Oil on the Improvement of Learning and Memory Function in Mice
Wu, R. T., Zhong, S., Ni, M., Zhu, X., Chen, Y., Chen, X., Zhang, L., & Chen, J. (2020) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2020/8617143 · Cited by 13
McLennan, P. L., & Pepe, S. (2015) · Heart Lung and Circulation · doi:10.1016/j.hlc.2015.06.825 · Cited by 12
Fish Oil Selectively Improves Heart Function in a Mouse Model of Lipid-induced Cardiomyopathy
Khan, R. S., Chokshi, A. D., Drosatos, K., Jiang, H., Yu, S., Harris, C. R., Schulze, P. C., Homma, S., Blaner, W. S., Shulman, G. I., et al. (2013) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e318283d845 · Cited by 12
Cleanthous, X., Noakes, M., Brinkworth, G. D., Keogh, J. B., Williams, G., & Clifton, P. M. (2010) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2009.09.002 · Cited by 13
McKeown, P., Logan, K., McKinley, M. C., Young, I. S., & Woodside, J. V. (2009) · Proceedings of The Nutrition Society · doi:10.1017/s0029665109991856 · Cited by 13
Ong, H. T., & Cheah, J. S. (2008) · Chinese Medical Journal · doi:10.1097/00029330-200808020-00017 · Cited by 12
Nutraceuticals for the treatment of metabolic diseases: evidence from clinical practice
Derosa, G., & Maffioli, P. (2014) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.2015.995630 · Cited by 12
Kiage, J. N., Sampson, U. K. A., Lipworth, L. P., Fazio, S., Mensah, G. A., Yu, Q., Munro, H. M., Akwo, E. A., Dai, Q., Blot, W. J., et al. (2015) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2015.07.006 · Cited by 12
The secondary prevention of cardiovascular disease
Anand, S. S., Lonn, E., & Yusuf, S. (2005) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780198525738.003.0045 · Cited by 12
Omega-3 fatty acids, thrombosis and vascular disease
Harris, W. S. (2004) · International Congress Series · doi:10.1016/j.ics.2003.12.097 · Cited by 12
Toth, P. P. (2011) · Yearbook of Medicine · doi:10.1016/s0084-3873(11)00362-2 · Cited by 12
The emerging link between nutrition, inflammation and atherosclerosis
Paoletti, R., Poli, A., & Cignarella, A. (2006) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.4.3.385 · Cited by 11
For personal use. Only reproduce with permission from The Lancet.
Jung, J. H., Min, P., Moon, Y. J., Heum, W., & Shim (2004) · Cited by 12
Tacias-Pascacio, V. G., Abellanas-Pérez, P., de Andrades, D., Tavano, O. L., MENDES, A. A., Berenguer‐Murcia, Á., & Fernández‐Lafuente, R. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.142878 · Cited by 12
Marangoni, F., & Poli, A. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.06.039 · Cited by 12
Rizos, E. C., & Elisaf, M. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.02.050 · Cited by 11
Spruce Galactoglucomannan-Stabilized Emulsions Enhance Bioaccessibility of Bioactive Compounds
Zhao, H., Mikkonen, K. S., Kilpeläinen, P. O., & Lehtonen, M. (2020) · Foods · doi:10.3390/foods9050672 · Cited by 11
Omega n-3 Supplementation: Exploring the Cardiovascular Benefits Beyond Lipoprotein Reduction
Zambon, A., Pirillo, A., Zambon, S., Norata, G. D., & Catapano, A. L. (2020) · Current Atherosclerosis Reports · doi:10.1007/s11883-020-00893-1 · Cited by 11
Moyad, M. A. (2011) · Urologic Clinics of North America · doi:10.1016/j.ucl.2011.05.004 · Cited by 11
Peroxidized unsaturated fatty acids stimulate Toll-like receptor 4 signaling in endothelial cells
Mutoh, A., & Ueda, S. (2013) · Life Sciences · doi:10.1016/j.lfs.2013.03.019 · Cited by 12
Dietary Fatty Acids and Predementia Syndromes
Solfrizzi, V., Frisardi, V., Capurso, C. A., Introno, A. D., Colacicco, A. M., Vendemiale, G., Capurso, A., & Panza, F. (2009) · The Scientific World JOURNAL · doi:10.1100/tsw.2009.82 · Cited by 10
Volpe, M., Volpe, R., Gallo, G., Presta, V., Tocci, G., Folco, E., Peracino, A. P., Tremoli, E., & Trimarco, B. (2017) · High Blood Pressure & Cardiovascular Prevention · doi:10.1007/s40292-017-0211-6 · Cited by 11
Madsen, T., Christensen, J. H., Toft, E. S., Aardestrup, I. V., Lundbye‐Christensen, S., & Schmidt, E. B. (2011) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607110371807 · Cited by 11
Ling, P., Puder, M., & Bistrian, B. R. (2012) · Metabolism · doi:10.1016/j.metabol.2012.03.007 · Cited by 11
Skae, M. S., Avatapalle, B., Banerjee, I., Rigby, L., Vail, A., Foster, P., Charalambous, C., Bowden, L., Padidela, R., Patel, L., et al. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00031 · Cited by 11
Lipid-lowering therapy for prevention of ventricular tachyarrhythmias
Anderson, K. P. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00497-2 · Cited by 11
Acute Heart Failure—Basic Pathomechanism and New Drug Targets
Rupp, H., Rupp, T. P., Alter, P. J., & Maisch, B. (2006) · Herz · doi:10.1007/s00059-006-2911-x · Cited by 11
Poisson, acides gras oméga 3 et risque cardiovasculaire : données épidémiologiques
Lecerf, J. (2004) · Cahiers de Nutrition et de Diététique · doi:10.1016/s0007-9960(04)94447-1 · Cited by 13
Effects of dietary fat intake in sudden death: Reduction of death with omega-3 fatty acids
Lee, K. W., Hamaad, A., MacFadyen, R. J., & Lip, G. Y. H. (2004) · Current Cardiology Reports · doi:10.1007/s11886-004-0040-9 · Cited by 11
Marine n-3 fatty acids and thrombosis
Schmidt, E. B. (2003) · Thrombosis Research · doi:10.1016/j.thromres.2003.09.001 · Cited by 11
Dyslipidemia in Chronic Kidney Disease
Streja, E., & Streja, D. A. (2022) · Wiley eBooks · doi:10.1002/9781119105954.ch34 · Cited by 11
Structural insights into endogenous ligand selectivity and activation mechanisms of FFAR1 and FFAR2
Ke, Y., Huang, Y., Yi, C., Ma, L., Chu, X., Wu, B., Zhao, Q., & Han, S. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.115024 · Cited by 10
Bernhard, B., Heydari, B., Abdullah, S. M., Francis, S. A., Lumish, H. S., Wang, W., Jerosch‐Herold, M., Harris, W. S., & Kwong, R. Y. K. (2024) · International Journal of Cardiology · doi:10.1016/j.ijcard.2023.131698 · Cited by 11
The Role of Omega-3 Fatty Acids in Diets
Gómez‐Candela, C., Roldán-Puchalt, M. C., Milla, S. P., Plaza, B. L., & Bermejo, L. M. (2015) · Journal of the American College of Nutrition · doi:10.1080/07315724.2015.1080111 · Cited by 10
Schunck, W. (2016) · Journal of Lipid Research · doi:10.1194/jlr.c071084 · Cited by 10
Metadata
- Authors
- Marchioli, R., Barzi, F., Bomba, E., Chieffo, C., Di Gregorio, D., Di Mascio, R., Franzosi, M. G., Geraci, E., Levantesi, G., Maggioni, A. P., Mantini, L., Marfisi, R. M., Mastrogiuseppe, G., Mininni, N., Nicolosi, G. L., Santini, M., Schweiger, C., Tavazzi, L., Tognoni, G., Tucci, C., & Valagussa, F.
- Affiliations
- Mario Negri Institute for Pharmacological Research (IT)
- From the Department of Clinical Pharmacology and Epidemiology, Consorzio Mario Negri Sud, Santa Maria Imbaro, Chieti (R.M., F.B., E.B., R.D.M., R.M.M., G.T.); Ospedale Civile, Caserta (C.C.); Ospedale Civile, Lanciano (D.D.G., L.M., G.M., C.T.); Department of Cardiovascular Research, Istituto Mario Negri, Milano (M.G.F.); Ospedale Cervello, Palermo (E.G.); Ospedale Civile, Vasto (G.L.); Centro Studi ANMCO, Firenze (A.P.M.); Ospedale Civile, Napoli (N.M.); Ospedale S. Maria degli Angeli, Pordenone (G...
- Corresponding author
- Marchioli, Roberto
- Venue
- Circulation
- Published
- 2002-04-23
- Volume
- 105
- Issue
- 16
- Pages
- 1897-1903
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2128788220
- Cited by
- 1,311
- References
- 36
- Citations by year
- 2026: 6 · 2025: 14 · 2024: 27 · 2023: 18 · 2022: 21 · 2021: 17 · 2020: 30 · 2019: 20 · 2018: 33 · 2017: 42 · 2016: 42 · 2015: 49 · 2014: 64 · 2013: 87 · 2012: 84
- FWCI
- 60.57
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Circulation (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Bristol-Myers Squibb
- Istituto di Ricerche Farmacologiche Mario Negri - IRCCS
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Health and Mental Health
- Keywords
- omega-3 fatty acids, myocardial infarction, sudden death, mortality, vitamin E, antiarrhythmic effect, time course of treatment effects, cardiovascular mortality, coronary artery disease, cerebrovascular events
- MeSH terms
- Anti-Arrhythmia Agents, Female, Follow-Up Studies, Humans, Italy, Kinetics, Lipids, Male, Middle Aged, Myocardial Infarction, Fatty Acids, Omega-3, Death, Sudden, Cardiac, Dietary Supplements
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
